昊海生物科技(06826.HK)拟597.4万英镑购买CONTAMAC HOLDINGS 9%股权
格隆汇5月21日丨昊海生物科技(06826.HK)发布公告,于2021年5月21日,Haohai Healthcare Holdings(公司间接全资子公司)与卖方订立购股协议,据此卖方同意出售及Haohai Healthcare Holdings同意购买目标公司CONTAMAC HOLDINGS LIMITED的9%权益,对价为597.4万英镑。
目标公司为一家于英国注册成立的有限公司,主要从事制造隐形眼镜及人工晶状体材料,包括矽胶水凝胶材料、透气材料、亲水透镜材料以及疏水和亲水的眼内透镜材料。于交易完成后,Haohai Healthcare Holdings将成为目标公司79%权益的持有人。
公司表示,目标公司股东此前已于2017年的先前收购中协定若干认沽期权权利及认购期权权利,其中于卖方的锁定期届满后,卖方具有将待售股份出售予买方的认沽期权权利,而买方则具有自卖方购买待售股份的认购期权权利。考虑到卖方的年事已高及目标公司对集团的重要性,卖方及买方均已同意通过签订购股协议行使其权利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.